Close

Press Releases

PCI Broadens Clinical Trial Service Offerings at Berlin Facility

PCI Pharma Services is today pleased to announce a new milestone in our global Clinical footprint with the expansion of cold chain clinical supply storage and distribution capabilities at our Berlin location, a major investment that will provide global...

CapsCanada Launches Liquid-Filled Hard Capsule Manufacturing Service in North America

CapsCanada, a Lyfe Group company and leader in capsule technology for over three decades, is pleased to announce the launch of a new liquid-filled hard capsule manufacturing service. CapsCanada’s objective is to support the entire manufacturing process, from formulation...

Syntegon presents Versynta FFP, the modular small batch solution for liquid pharmaceuticals

There has been a noticeable shift in the pharmaceutical industry: more and more high-priced biotech drugs for small patient populations require highly flexible filling solutions that achieve precise product yields at low output. Accordingly, Syntegon Technology has developed a...

Softbox successfully supports Pfizer in the global cold chain distribution of Covid-19 vaccines

Softbox, a leading global innovator and provider of passive temperature control packaging solutions for the pharmaceutical, life science and cold chain logistics industries, is proud to support Pfizer in the distribution of Covid-19 vaccines through the supply of a...

AARDEX and Schreiner MediPharm reinforce their collaboration to enhance Medication Adherence Management

AARDEX Group, the world leader in medication adherence solutions, continues to build up its ecosystem and to bridge GMP to GCP world in Clinical Trials by reinforcing their strategic partnership with Schreiner MediPharm, a global specialist in innovative functional...

Moderna Announces Supply Agreement to Provide 13 Million Doses of COVID-19 Vaccine Moderna to the Philippines

Moderna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, announced a supply agreement with the Government of The Philippines for 13 million doses of the COVID-19 Vaccine Moderna. Under the terms of this agreement, deliveries would begin...

CureVac and Novartis Sign Initial Agreement on Manufacturing of COVID-19 Vaccine Candidate, CVnCoV

CureVac N.V., a global biopharmaceutical company developing a new class of transformative medicines based on messenger ribonucleic acid (mRNA), and Novartis AG announced that they have signed an initial agreement for the manufacturing of CureVac’s COVID-19 vaccine candidate, CVnCoV....

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate »